nejm semaglutide cardiovascular Presented at #ACC25: Among participants with type 2 diabetes and disease, chronic kidney disease, or both, oral (14 mg) was associated with a lower risk of cardiovascular events than placebo NEJM: Once-Weekly Semaglutide in Adults

Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes

It also slows stomach emptying, which supports how GLP-1 controls appetite naturally

This formula works as a natural GLP-1 alternative (Like Ozempic) by supporting the bodys natural hormone regulation and stress response, helping to manage cravings and promote balanced energy throughout the day

There is a currently a lot of activity by pharmaceutical companies to get a slice of this pie. Dr Henrik Sillesen, the Airfinitys chief medical officer, previously said: Obesity drugs are a modern-day gold rush for drugmakers

PMID: 18300658